CSU "Analytical Spectrometry" provides a range of services to the pharmaceutical and biotechnology industries. We focus on quantitative determination of pharmaceuticals and biomarkers in physiological fluids and tissues (BE, PK, PD, BA, and TDM) in accordance with the most recent regulatory agencies requirements (FDA, EMA) and GCLP principles.
Safety report and final report development for clinical and pre-clinical studies in accordance with local and international requirements.
More than 145 bioanalytical methods for drugs and biomarkers determination were developed in CSU "Analytical Spectrometry". We ensure that our clients receive professional and reliable bioanalytical support with high quality levels and delivery schedules. We use state-of-the-art equipment and the latest techniques to develop highly exacting analytical methods that are validated in accordance with FDA and EMA standarts.
If you have any questions. don`t hesitate to contact us.